Hims & Hers management's 2030 guidance includes $6.5 billion in revenue and $1.3 billion in adjusted EBITDA. Read why HIMS ...

Prosecutors in Karen Read’s second murder trial attempted to build on earlier testimony from Jennifer McCabe, who overheard ...

Hims & Hers Health shares have surged 32.4% since Tuesday's session open. The stock is gaining following a standout ...

One expert said it sounded like the mother is "blind to her child's faults and responds defensively to anyone laying down healthy boundaries towards her child." ...

Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...

Hims & Hers ( HIMS 19.03%) stock soared 18.2% in trading on Tuesday after the company reported first-quarter revenue growth ...

During a recent interview, Maria Perrin announced a few developments in how PPL will handle CDPAP going forward, including ...

As investors wait for U.S. trade deals, an agreement with the U.K. is set to be signed this week, according to a [Financial ...

Palantir Technologies shares are down nearly 8% after the software group's stellar earnings could not prevent some profit taking after the stock's strong rally to near record highs.

However, the March surge in the trade imbalance is caused by companies scrambling to import products after Trump announced -- ...

NEW YORK (AP) — U.S. stocks are sinking Tuesday as AI mania on Wall Street loses more steam and as more companies scrub their ...

Hims & Hers Health, Inc.'s subscriber growth, Novo Nordisk partnership, and FDA pill approval could boost financials. Click ...